For investors only
All about the drug candidate arfolitixorin
and related information
ENA 2024, poster
Oncosyne AS and Akershus University Hospital in Oslo, have had an abstract approved to present at ENA 2024 in Barcelona, Spain between October 23-25, 2024.
Information about the poster
Title: ”Dose-dependent cytotoxicity of arfolitixorin, a direct-acting folate, versus leucovorin with 5-fluorouracil in patient-derived colorectal cancer tumoroids (PDTs)”.
Presenter: Dr. Jarle Bruun, PhD, Chief Executive Officer, Oncosyne AS.
Abstract Number: #510-LB
Poster Number: #PB-510
The abstract will be published online on ENA´s website on 23 October.
The poster will be shown in the Exhibition Hall from 12:00 p.m. on 23 October and will also be available below after the congress on ENA´s website:
Watch the recap video with Jarle Bruun, Oncosyne AS and his reflection from the ENA congress 2024 and the presenting poster >>
Last updated 11-05-2024
